AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Organon & Co.

$13.64 +$6.40 (+88.40%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$13.63
Day Range
$13.6$13.65
Year Range
$5.69$13.79
Market Cap
3.58B
AVG Volume
3.11M
Trailing/Forward PE
17.27/3.76
PEG ratio
2.07
Dividend Yield
0.59%
Next Earnings Date
2026-11-09
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
02B4B6B8B202020212022202320242025
OGN Revenue (USD) by year
PeriodRevenue (USD)
20256.22B
20246.4B
20236.26B
20226.17B
20216.33B
20206.53B
Net Income (USD)
01B2B3B202020212022202320242025
OGN Net Income (USD) by year
PeriodNet Income (USD)
2025187M
2024864M
20231.02B
2022917M
20211.35B
20202.16B
Operating Income (USD)
01B2B3B202020212022202320242025
OGN Operating Income (USD) by year
PeriodOperating Income (USD)
20251.24B
20241.49B
20231.33B
20221.72B
20211.92B
20202.85B
EBITDA (USD)
01B2B3B202020212022202320242025
OGN EBITDA (USD) by year
PeriodEBITDA (USD)
20251.3B
20241.61B
20231.44B
20221.76B
20211.98B
20202.99B
Cash Flows (USD)
01B2B3B202020212022202320242025
OGN Cash Flows (USD) by year
PeriodCash Flows (USD)
2025404M
2024603M
2023538M
2022470M
20212.33B
20201.91B
EPS (USD)
02.557.510202020212022202320242025
OGN EPS (USD) by year
PeriodEPS (USD)
20250.71
20243.33
20234
20223.59
20215.32
20208.53
Expenses (USD)
01B2B3BR&DSG&ACapex202020212022202320242025
OGN Expenses (USD) by year
PeriodExpenses (USD)
20252.38B
20242.56B
20232.68B
20222.56B
20212.33B
20201.84B
Cash & Debt (USD)
02.5B5B7.5B10BCashLong Term DebtShort Term Debt202020212022202320242025
OGN Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2025574M
2024675M
2023693M
2022706M
2021737M
202012M
Debt ratios
00.511.5202320242025
OGN Debt ratios by year
PeriodDebt ratios
20251.35
20241.23
20231.01
Margins
0%20%40%60%80%202020212022202320242025
OGN Margins by year
PeriodMargins
202553.59%
202458.02%
202359.84%
202262.99%
202162.46%
202067.56%
Return on Capital
-1500%-1000%-500%0%500%202020212022202320242025
OGN Return on Capital by year
PeriodReturn on Capital
202524.87%
2024183.05%
2023-1461.43%
2022-102.8%
2021-89.59%
202039.37%
Shares Outstanding
0100M200M300M202020212022202320242025
OGN Shares Outstanding by year
PeriodShares Outstanding
2025260.17M
2024257.69M
2023255.62M
2022254.37M
2021253.55M
2020253.13M
Dividends (USD)
00.511.5202120222023202420252026
OGN Dividends (USD) by year
PeriodDividends (USD)
20260.06
20250.34
20241.12
20231.12
20221.12
20210.56
Employee Count
02.5K5K7.5K10K20212022202320242025
OGN Employee Count by year
PeriodEmployee Count
202510K
202410K
202310K
202210K
20219.3K
Book Value Per Share (USD)
-100102030202020212022202320242025
OGN Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20252.89
20241.83
2023-0.27
2022-3.51
2021-5.95
202021.67
Total Assets (USD)
05B10B15B202020212022202320242025
OGN Total Assets (USD) by year
PeriodTotal Assets (USD)
202512.87B
202413.1B
202312.06B
202210.96B
202110.68B
202010.11B
PE Ratio
05101520med 3.81Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
OGN PE Ratio by year
PeriodPE Ratio
Sep 2617.14
Sep 2617.31
Aug 2617.29
Aug 2617.28
Aug 2617.24
Aug 2617.09
Jul 2617.03
Jul 2614.31
Jul 2614.31
Jul 2614.31
Jul 2614.34
Jun 2614.29
Jun 2614.21
Jun 2614.23
Jun 2614.14
May 2614.12
May 2614.21
May 2614.18
May 2614.13
May 2618.49
Apr 2615.67
Apr 2613.58
Apr 2612.29
Apr 268.85
Mar 268.13
Mar 268.39
Mar 268.83
Mar 269.13
Feb 2610.14
Feb 264.2
Feb 263.83
Feb 264.26
Jan 264.43
Jan 265.06
Jan 264.55
Jan 264.18
Jan 263.76
Dec 253.73
Dec 253.54
Dec 253.72
Dec 253.71
Nov 254
Nov 253.74
Nov 253.91
Nov 252.52
Oct 252.51
Oct 253.4
Oct 253.45
Oct 253.56
Oct 254.09
Sep 253.79
Sep 253.88
Sep 253.95
Sep 253.85
Aug 253.5
Aug 253.5
Aug 253.51
Aug 253.42
Aug 253.35
Jul 253.51
Jul 253.25
Jul 253.42
Jul 253.42
Jun 253.39
Jun 253.35
Jun 253.45
Jun 253.29
May 253.17
May 252.99
May 253.11
May 252.99
May 253.3
Apr 253.64
Apr 253.32
Apr 253.33
Apr 253.89
Mar 254.33
Mar 254.59
Mar 254.57
Mar 254.61
Feb 254.45
Feb 253.07
Feb 253.02
Feb 252.89
Jan 253.08
Jan 253.16
Jan 253.12
Jan 253.14
Jan 253.06
Dec 242.98
Dec 242.89
Dec 243.03
Dec 242.99
Nov 243.14
Nov 243.02
Nov 242.97
Nov 243.17
Nov 243.58
Oct 244.42
Oct 244.53
Free Cash Flow Yield
10%20%30%40%med 17.9%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
OGN Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 2613.9%
Sep 2613.76%
Aug 2613.78%
Aug 2613.79%
Aug 2613.82%
Aug 2613.94%
Jul 2614%
Jul 2617.44%
Jul 2617.44%
Jul 2617.44%
Jul 2617.4%
Jun 2617.47%
Jun 2617.56%
Jun 2617.55%
Jun 2617.65%
May 2617.68%
May 2617.56%
May 2617.6%
May 2617.66%
May 2611.68%
Apr 2613.79%
Apr 2615.91%
Apr 2617.59%
Apr 2624.42%
Mar 2626.59%
Mar 2625.75%
Mar 2624.45%
Mar 2623.67%
Feb 2621.3%
Feb 2626.88%
Feb 2629.46%
Feb 2626.52%
Jan 2625.49%
Jan 2622.31%
Jan 2624.85%
Jan 2627.05%
Jan 2630.07%
Dec 2530.32%
Dec 2531.88%
Dec 2530.36%
Dec 2530.49%
Nov 2528.24%
Nov 2530.24%
Nov 2528.91%
Nov 2527.35%
Oct 2527.47%
Oct 2520.24%
Oct 2519.98%
Oct 2519.32%
Oct 2516.84%
Sep 2518.16%
Sep 2517.74%
Sep 2517.41%
Sep 2517.86%
Aug 2519.68%
Aug 2519.66%
Aug 2519.64%
Aug 2520.11%
Aug 2523.9%
Jul 2522.83%
Jul 2524.64%
Jul 2523.45%
Jul 2523.4%
Jun 2523.64%
Jun 2523.9%
Jun 2523.21%
Jun 2524.38%
May 2525.28%
May 2526.82%
May 2525.78%
May 2526.76%
May 2524.3%
Apr 2519.18%
Apr 2521.04%
Apr 2520.93%
Apr 2517.93%
Mar 2516.13%
Mar 2515.2%
Mar 2515.28%
Mar 2515.16%
Feb 2515.69%
Feb 2516.57%
Feb 2516.8%
Feb 2517.56%
Jan 2516.5%
Jan 2516.07%
Jan 2516.31%
Jan 2516.2%
Jan 2516.63%
Dec 2417.05%
Dec 2417.61%
Dec 2416.78%
Dec 2416.98%
Nov 2416.18%
Nov 2416.8%
Nov 2417.08%
Nov 2416%
Nov 2414.21%
Oct 2418.17%
Oct 2417.7%
Price to Sales
0.20.40.60.8med 0.44Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
OGN Price to Sales by year
PeriodPrice to Sales
Sep 260.58
Sep 260.59
Aug 260.59
Aug 260.59
Aug 260.59
Aug 260.58
Jul 260.58
Jul 260.57
Jul 260.57
Jul 260.57
Jul 260.57
Jun 260.57
Jun 260.57
Jun 260.57
Jun 260.56
May 260.56
May 260.57
May 260.57
May 260.56
May 260.56
Apr 260.47
Apr 260.41
Apr 260.37
Apr 260.27
Mar 260.24
Mar 260.25
Mar 260.27
Mar 260.27
Feb 260.31
Feb 260.33
Feb 260.3
Feb 260.34
Jan 260.35
Jan 260.4
Jan 260.36
Jan 260.33
Jan 260.3
Dec 250.3
Dec 250.28
Dec 250.3
Dec 250.29
Nov 250.32
Nov 250.3
Nov 250.31
Nov 250.28
Oct 250.28
Oct 250.38
Oct 250.38
Oct 250.4
Oct 250.46
Sep 250.42
Sep 250.43
Sep 250.44
Sep 250.43
Aug 250.39
Aug 250.39
Aug 250.39
Aug 250.38
Aug 250.4
Jul 250.42
Jul 250.39
Jul 250.41
Jul 250.41
Jun 250.4
Jun 250.4
Jun 250.41
Jun 250.39
May 250.38
May 250.36
May 250.37
May 250.36
May 250.39
Apr 250.49
Apr 250.45
Apr 250.45
Apr 250.53
Mar 250.58
Mar 250.62
Mar 250.62
Mar 250.62
Feb 250.6
Feb 250.62
Feb 250.61
Feb 250.59
Jan 250.63
Jan 250.64
Jan 250.63
Jan 250.64
Jan 250.62
Dec 240.61
Dec 240.59
Dec 240.61
Dec 240.61
Nov 240.64
Nov 240.61
Nov 240.6
Nov 240.64
Nov 240.73
Oct 240.7
Oct 240.71
EV/EBITDA
6789med 7.53Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
OGN EV/EBITDA by year
PeriodEV/EBITDA
Sep 268.42
Sep 268.45
Aug 268.45
Aug 268.45
Aug 268.44
Aug 268.42
Jul 268.41
Jul 267.93
Jul 267.93
Jul 267.93
Jul 267.93
Jun 267.92
Jun 267.91
Jun 267.91
Jun 267.9
May 267.89
May 267.91
May 267.91
May 267.9
May 268.99
Apr 268.59
Apr 268.29
Apr 268.1
Apr 267.61
Mar 267.5
Mar 267.54
Mar 267.6
Mar 267.65
Feb 267.79
Feb 266.52
Feb 266.4
Feb 266.53
Jan 266.59
Jan 266.79
Jan 266.62
Jan 266.51
Jan 266.37
Dec 256.36
Dec 256.31
Dec 256.36
Dec 256.36
Nov 256.45
Nov 256.37
Nov 256.42
Nov 256.63
Oct 256.63
Oct 257.04
Oct 257.06
Oct 257.11
Oct 257.36
Sep 257.22
Sep 257.26
Sep 257.29
Sep 257.25
Aug 257.08
Aug 257.09
Aug 257.09
Aug 257.05
Aug 257.28
Jul 257.36
Jul 257.23
Jul 257.31
Jul 257.32
Jun 257.3
Jun 257.28
Jun 257.33
Jun 257.25
May 257.19
May 257.1
May 257.16
May 257.1
May 257.25
Apr 257.16
Apr 256.99
Apr 257
Apr 257.3
Mar 257.53
Mar 257.67
Mar 257.66
Mar 257.68
Feb 257.59
Feb 257.68
Feb 257.65
Feb 257.54
Jan 257.69
Jan 257.76
Jan 257.72
Jan 257.74
Jan 257.67
Dec 247.61
Dec 247.53
Dec 247.65
Dec 247.62
Nov 247.74
Nov 247.65
Nov 247.6
Nov 247.77
Nov 248.11
Oct 248.64
Oct 248.72
Price/Operating Cashflow
12345med 3.32Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
OGN Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 264.86
Sep 264.91
Aug 264.9
Aug 264.9
Aug 264.89
Aug 264.85
Jul 264.83
Jul 264.14
Jul 264.14
Jul 264.14
Jul 264.15
Jun 264.14
Jun 264.11
Jun 264.12
Jun 264.09
May 264.09
May 264.11
May 264.1
May 264.09
May 264.94
Apr 264.19
Apr 263.63
Apr 263.28
Apr 262.36
Mar 262.17
Mar 262.24
Mar 262.36
Mar 262.44
Feb 262.71
Feb 262.22
Feb 262.02
Feb 262.25
Jan 262.34
Jan 262.67
Jan 262.4
Jan 262.21
Jan 261.98
Dec 251.97
Dec 251.87
Dec 251.96
Dec 251.96
Nov 252.11
Nov 251.97
Nov 252.06
Nov 252.13
Oct 252.12
Oct 252.88
Oct 252.92
Oct 253.02
Oct 253.46
Sep 253.21
Sep 253.29
Sep 253.35
Sep 253.27
Aug 252.96
Aug 252.97
Aug 252.97
Aug 252.9
Aug 252.68
Jul 252.81
Jul 252.6
Jul 252.73
Jul 252.74
Jun 252.71
Jun 252.68
Jun 252.76
Jun 252.63
May 252.53
May 252.39
May 252.49
May 252.39
May 252.64
Apr 253.35
Apr 253.05
Apr 253.07
Apr 253.58
Mar 253.98
Mar 254.22
Mar 254.2
Mar 254.24
Feb 254.09
Feb 254.22
Feb 254.16
Feb 253.98
Jan 254.24
Jan 254.35
Jan 254.28
Jan 254.31
Jan 254.2
Dec 244.1
Dec 243.97
Dec 244.16
Dec 244.12
Nov 244.32
Nov 244.16
Nov 244.09
Nov 244.37
Nov 244.92
Oct 244.14
Oct 244.25
Price to Book
010203040med 3.88Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
OGN Price to Book by year
PeriodPrice to Book
Sep 263.56
Sep 263.6
Aug 263.59
Aug 263.59
Aug 263.58
Aug 263.55
Jul 263.54
Jul 263.9
Jul 263.9
Jul 263.9
Jul 263.91
Jun 263.89
Jun 263.87
Jun 263.88
Jun 263.85
May 263.85
May 263.87
May 263.86
May 263.85
May 264.6
Apr 263.9
Apr 263.38
Apr 263.05
Apr 262.2
Mar 262.02
Mar 262.09
Mar 262.2
Mar 262.27
Feb 262.52
Feb 262.32
Feb 262.12
Feb 262.36
Jan 262.45
Jan 262.8
Jan 262.51
Jan 262.31
Jan 262.08
Dec 252.06
Dec 251.96
Dec 252.06
Dec 252.05
Nov 252.21
Nov 252.07
Nov 252.16
Nov 252.4
Oct 252.39
Oct 253.25
Oct 253.29
Oct 253.4
Oct 253.9
Sep 253.62
Sep 253.71
Sep 253.78
Sep 253.68
Aug 253.34
Aug 253.34
Aug 253.35
Aug 253.27
Aug 254.64
Jul 254.86
Jul 254.5
Jul 254.73
Jul 254.74
Jun 254.69
Jun 254.64
Jun 254.78
Jun 254.55
May 254.39
May 254.13
May 254.3
May 254.14
May 254.56
Apr 256.66
Apr 256.07
Apr 256.1
Apr 257.12
Mar 257.92
Mar 258.4
Mar 258.36
Mar 258.43
Feb 258.14
Feb 258.09
Feb 257.98
Feb 257.64
Jan 258.13
Jan 258.34
Jan 258.22
Jan 258.28
Jan 258.06
Dec 247.87
Dec 247.62
Dec 247.99
Dec 247.9
Nov 248.29
Nov 247.98
Nov 247.85
Nov 248.38
Nov 249.44
Oct 2430.66
Oct 2431.46
Organon & Co.
OGN
Stockpicker

Video analysis: OGN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: OGN

Orogen Royalties Acquires the Serpent Gold Project in Nevada

accessnewswire.com · 10 Sep 2026

Orogen Royalties Acquires the Serpent Gold Project in Nevada

VANCOUVER, BC / ACCESS Newswire / September 10, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce the acquisition of the Serpent gold project in Nevada, USA. Project Highlights Serpent is a district scale, low-sulphidation epithermal gold target located in central Nevada Focused on a series of gold-bearing structures within an eight-kilometre trend of alteration Highly anomalous gold in rocks (up to 0.95 grams per tonne ("g/t") gold) associated with the shallow expression of an epithermal deposit Underexplored with no evidence of historical drilling Generated in partnership with Altius Minerals Corporation The Serpent project is available for option or sale.

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

zacks.com · 8 Sep 2026

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Orogen Royalties Acquires Two Gold Projects in Southwest Utah

accessnewswire.com · 2 Sep 2026

Orogen Royalties Acquires Two Gold Projects in Southwest Utah

VANCOUVER, BC / ACCESS Newswire / September 2, 2026 / Orogen Royalties Inc. ("Orogen" or the "Company") (TSXV:OGN)(OTCQX:OGNNF) is pleased to announce the acquisition of the Toro de Oro and El Gigante gold projects in Southwest Utah, USA. Project Highlights Two low-sulphidation epithermal targets located in caldera complexes of southwest Utah Toro de Oro is centered on an extensive footprint of steam cap alteration and chalcedonic vein sets indicating the high-level expression of an epithermal system, geologically similar to AngloGold Ashanti's Arthur Project El Gigante contains two separate quartz veins up to and exceeding three metres wide and over 350 metres long with strong similarities to the surface expression of First Majestic's Ermitaño vein.

Bank of America Corp DE Has $4.42 Million Stock Position in Organon & Co. $OGN

defenseworld.net · 29 Aug 2026

Bank of America Corp DE Has $4.42 Million Stock Position in Organon & Co. $OGN

Bank of America Corp DE reduced its position in shares of Organon and Co. (NYSE: OGN) by 58.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 738,502 shares of the company's stock after selling 1,041,346 shares during the period. Bank of America

National Can-RISE Study to Help Close Critical Gaps in Menopause Research

globenewswire.com · 27 Aug 2026

National Can-RISE Study to Help Close Critical Gaps in Menopause Research

TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Women's Health Collective Canada (WHCC) and the Partnership for Women's Health Research Canada (PWHR), in partnership with GreenShield and supported by a charitable grant from Organon, have launched the Researching Information, Support, and Equity During the Menopause Transition in Canada (Can-RISE) Study. As the first national investigator-led study focused on Canadian women's experiences of menopause and the menopausal transition, Can-RISE is led by PWHR with funding support from WHCC.

Organon & Co. (NYSE:OGN) Sets New 52-Week High  – Still a Buy?

defenseworld.net · 25 Aug 2026

Organon & Co. (NYSE:OGN) Sets New 52-Week High – Still a Buy?

Organon and Co. (NYSE: OGN - Get Free Report) reached a new 52-week high during trading on Tuesday. The stock traded as high as $13.76 and last traded at $13.7540, with a volume of 4583387 shares trading hands. The stock had previously closed at $13.75. Analyst Ratings Changes Several research firms have recently weighed in

Orogen Royalties Acquires a Royalty on the Haldane Silver Project

accessnewswire.com · 20 Aug 2026

Orogen Royalties Acquires a Royalty on the Haldane Silver Project

VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce it has acquired a 2% Net Smelter Return ("NSR") royalty (the "Royalty") on the Haldane silver project in Yukon Territory, Canada. Haldane Royalty Highlights 1,2,3,4 Haldane is a high-grade silver project owned by Silver North Resources Ltd.

Orogen Royalties and Aurum Discovery form Generative Alliance in Norway

accessnewswire.com · 17 Aug 2026

Orogen Royalties and Aurum Discovery form Generative Alliance in Norway

VANCOUVER, BC / ACCESS Newswire / August 17, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce the formation of a generative exploration alliance (the "Alliance") with a subsidiary of Aurum Discovery ("Aurum"), a private prospect generator based in Ireland. The Alliance will focus on generating gold and silver targets in prospective mineral belts within Norway.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.